Latest action: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Bill is filed in its originating chamber and assigned a number.
Filed in the Senate.
Next: In Committee
Members of the committee(s) the bill was referred to
Bill aims to speed up approval and use of life-saving medical treatments across states.
The problem
Patients in some states may wait longer to access new treatments approved in other states. Medical licensing rules differ by state, potentially delaying access to helpful therapies.
The proposal
Creates reciprocal recognition of state-approved treatments and medical licenses, allowing faster patient access to therapies without repeating approval processes in each state.
The impact
Patients gain faster treatment access. States may see reduced regulatory control. Healthcare providers must follow new interstate rules. Pharmaceutical companies face streamlined approval pathways.
Patients could receive approved treatments more quickly without waiting for each state's separate approval. This is especially important for serious illnesses where time matters greatly.
Streamlining approval processes may lower administrative costs for hospitals and drug makers. These savings could reduce overall healthcare expenses.
Faster pathways to patients may encourage drug and treatment companies to develop new therapies. This could lead to more life-saving options.
Reduces confusion from different rules in different states. Patients receive same treatment access regardless of where they live.
States with stricter safety rules must accept treatments from states with weaker standards. This could expose patients to inadequately tested treatments.
States lose ability to make their own health and safety decisions. Local lawmakers have less power to protect their citizens.
Treatments approved in some states but not others could create unfair situations. Wealthy patients might seek out less-safe treatments.
Without individual state oversight, fraudulent or ineffective treatments might spread between states. Oversight and accountability become harder.
Generated by AI from the bill text. Not a prediction and not legal or policy advice. The percentage is the model's own rating of each item — self-reported, and not a measure of how accurate it is.
Loading map…
Loading...
0 citizens have already voted
Free · No spam · See how your representatives voted
Be the first to weigh in
Your vote starts the conversation
How citizen engagement works
Citizens vote & comment
Public opinion data is aggregated and updated in real time.
Patterns become visible
Representatives can see constituent sentiment broken down by district.
Your voice on the record
Contact your rep directly — one constituent call can shift a staffer's priority list.
Research shows that constituent contacts — especially calls — are among the most effective ways to influence a legislator's position on active bills.
Senate LDA lobbying disclosures
Couldn't load lobbying disclosures right now.